190
Ovid Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
131
FY23:
110
FY24:
55.9
FY25:
74.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.07
FY22:
23.9
FY23:
34.4
FY24:
36.2
FY25:
76.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
195
FY22:
155
FY23:
144
FY24:
92.2
FY25:
151
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.8
FY22:
6.99
FY23:
11.5
FY24:
10.5
FY25:
8.29
(negative)
millions USD
FY21:
0
FY22:
16.0
FY23:
44.8
FY24:
13.4
FY25:
12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
180
FY22:
132
FY23:
87.8
FY24:
68.2
FY25:
131
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
195
FY22:
155
FY23:
144
FY24:
92.2
FY25:
151
All amounts in millions USD